|
Name |
2-Acetyl-3-ethylpyrazine
|
Molecular Formula | C8H10N2O | |
IUPAC Name* |
1-(3-ethylpyrazin-2-yl)ethanone
|
|
SMILES |
CCC1=NC=CN=C1C(=O)C
|
|
InChI |
InChI=1S/C8H10N2O/c1-3-7-8(6(2)11)10-5-4-9-7/h4-5H,3H2,1-2H3
|
|
InChIKey |
PPJSYGVFDJEMRP-UHFFFAOYSA-N
|
|
Synonyms |
2-Acetyl-3-ethylpyrazine; 32974-92-8; 1-(3-ethylpyrazin-2-yl)ethanone; 1-(3-Ethylpyrazinyl)ethan-1-one; Ethanone, 1-(3-ethylpyrazinyl)-; 2-Acetyl-3-ethyl-1,4-diazine; 2-acetyl-3-ethyl pyrazine; 1-(3-ethylpyrazin-2-yl)ethan-1-one; 1-(3-Ethylpyrazinyl)ethanone; FEMA No. 3250; Ethanone, 1-(ethylpyrazinyl)-; 3-Ethyl-2-acetylpyrazine; Ethanone, 1-(3-ethyl-2-pyrazinyl)-; 2-Ethyl-3-acetyl pyrazine; AQ03N14XTL; Pyrazine, 2-acetyl-3-ethyl; 2-ACETYL ETHYLPYRAZINE; 1-(3-Ethyl-2-pyrazinyl)ethanone; MFCD00038028; UNII-AQ03N14XTL; EINECS 251-316-2; acetyl-3-ethylpyrazine, 2-; SCHEMBL1532459; 1-(3-Ethylpyrazinyl)-Ethanone; DTXSID3067736; FEMA 3250; CHEBI:173401; ZINC1850550; 1-(3-Ethyl-2-pyrazinyl)-Ethanone; 1-(3-Ethylpyrazinyl)ethanone, 9CI; AC8556; 1-(3-Ethyl-pyrazin-2-yl)-ethanone; 2-Acetyl-3-ethylpyrazine, 98%, FG; AKOS005256376; FS-1047; HY-W039157; 2-ACETYL-3-ETHYLPYRAZINE [FHFI]; SY027477; DB-020324; CS-0096817; FT-0610950; 974A928; A821538; Q-100406; Q27274053; 1-(3-ethylpyrazin-2-yl)ethanone;2-Acetyl-3-ethylpyrazine
|
|
CAS | 32974-92-8 | |
PubChem CID | 61918 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 150.18 | ALogp: | 0.6 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 42.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.603 |
Caco-2 Permeability: | -4.387 | MDCK Permeability: | 0.00003590 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.742 | Plasma Protein Binding (PPB): | 29.44% |
Volume Distribution (VD): | 1.386 | Fu: | 71.89% |
CYP1A2-inhibitor: | 0.688 | CYP1A2-substrate: | 0.707 |
CYP2C19-inhibitor: | 0.079 | CYP2C19-substrate: | 0.698 |
CYP2C9-inhibitor: | 0.014 | CYP2C9-substrate: | 0.676 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.466 |
CYP3A4-inhibitor: | 0.01 | CYP3A4-substrate: | 0.238 |
Clearance (CL): | 4.817 | Half-life (T1/2): | 0.446 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.525 |
Drug-inuced Liver Injury (DILI): | 0.907 | AMES Toxicity: | 0.043 |
Rat Oral Acute Toxicity: | 0.665 | Maximum Recommended Daily Dose: | 0.438 |
Skin Sensitization: | 0.862 | Carcinogencity: | 0.178 |
Eye Corrosion: | 0.162 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.797 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000577 | 0.571 | D0XF8W | 0.279 | ||||
ENC000612 | 0.304 | D0P0HB | 0.250 | ||||
ENC001141 | 0.300 | D0L7UQ | 0.212 | ||||
ENC005053 | 0.267 | D0S1NZ | 0.204 | ||||
ENC000599 | 0.238 | D09DWL | 0.203 | ||||
ENC000640 | 0.227 | D0Q9JT | 0.200 | ||||
ENC000201 | 0.224 | D0C8EU | 0.193 | ||||
ENC000391 | 0.222 | D02CKX | 0.192 | ||||
ENC000106 | 0.222 | D0ZK8H | 0.190 | ||||
ENC000096 | 0.222 | D0VT8P | 0.190 |